Amylou C Dueck

Amylou C Dueck

UNVERIFIED PROFILE

Are you Amylou C Dueck?   Register this Author

Register author
Amylou C Dueck

Amylou C Dueck

Publications by authors named "Amylou C Dueck"

Are you Amylou C Dueck?   Register this Author

99Publications

3036Reads

48Profile Views

Brain MR Radiomics to Differentiate Cognitive Disorders.

J Neuropsychiatry Clin Neurosci 2019 14;31(3):210-219. Epub 2019 Jan 14.

The Department of Research, Mayo Clinic Arizona, Phoenix (Ranjbar); the Center for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences (Velgos); the Department of Biostatistics, Mayo Clinic Arizona, Phoenix (Dueck); the Department of Psychiatry and Psychology, Mayo Clinic Arizona, Phoenix (Geda); the Department of Neurology, Mayo Clinic Arizona, Phoenix (Geda), and the Department of Physiology and Biomedical Engineering, Mayo Clinic Arizona, Phoenix (Mitchell).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.neuropsych.17120366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626704PMC
March 2020

Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis.

Biol Blood Marrow Transplant 2019 Nov 6;25(11):2267-2273. Epub 2019 Jul 6.

Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.07.001DOI Listing
November 2019

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance).

Leuk Lymphoma 2019 Oct 27;60(10):2580-2583. Epub 2019 Mar 27.

Division of Hematology, The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1594218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764912PMC
October 2019

Analytical Methods for Observational Data to Generate Hypotheses and Inform Clinical Decisions.

Semin Radiat Oncol 2019 10;29(4):311-317

Division of Biomedical Statistics and Informatics, Mayo Clinic, Scottsdale, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2019.05.003DOI Listing
October 2019

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

J Rheumatol 2019 Aug 15;46(8):1053-1058. Epub 2019 Jan 15.

From the Department of Family Medicine, and Department of Medicine, McGill University, Montreal, Quebec; Institute for Work & Health, Toronto; OMERACT; Ottawa Hospital Research Institute, Ottawa Hospital; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Division of Rheumatology, Hospital for Special Surgery; Department of Medicine, Weill Cornell Medical School, New York, New York; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona; Medicine Service, VA Medical Center; Department of Medicine, School of Medicine, University of Alabama at Birmingham; Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California; SDG LLC, Cambridge, Massachusetts, USA; Sydney Medical School, and Sydney School of Public Health, University of Sydney; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District; Department of Rheumatology, Royal North Shore Hospital, Reserve Road, St Leonards; Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Melbourne; Discipline of Medicine, University of Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville; Department of Rheumatology, Royal Prince Alfred Hospital, Camperdown, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust; NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, France; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181123DOI Listing
August 2019

Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?

Leuk Lymphoma 2019 02 22;60(2):402-408. Epub 2018 Jul 22.

a Section of Biostatistics , Mayo Clinic , Scottsdale , AZ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1480768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363896PMC
February 2019

Reply to Comment on "Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment".

J Am Geriatr Soc 2019 01 5;67(1):192-193. Epub 2018 Oct 5.

Department of Biostatistics, Mayo Clinic Arizona, Scottsdale, AZ.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgs.15622
Publisher Site
http://dx.doi.org/10.1111/jgs.15622DOI Listing
January 2019

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events.

J Patient Rep Outcomes 2018 Dec 4;2(1):56. Epub 2018 Dec 4.

Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA.

View Article

Download full-text PDF

Source
https://jpro.springeropen.com/articles/10.1186/s41687-018-00
Publisher Site
http://dx.doi.org/10.1186/s41687-018-0086-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279753PMC
December 2018

Sorafenib for Advanced and Refractory Desmoid Tumors.

N Engl J Med 2018 12;379(25):2417-2428

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) - all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D. Anderson Cancer Center, University of Texas, Houston (V.R.); Mayo Clinic in Florida, Jacksonville (S.A.); Yale University, New Haven, CT (H.A.D.); University Health Network Princess Margaret Cancer Centre, Toronto (A.A.G.); University of Iowa-Holden Comprehensive Cancer Center, Iowa City (M.M.M.); University of Alabama at Birmingham Cancer Center, Birmingham (R.M.C.); Fox Chase Cancer Center, Philadelphia (S.M.); Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC (M.J.P.); Duke Cancer Institute, Duke University Medical Center, Durham (R.F.R.), and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill (E.B.) - both in North Carolina; Dayton National Cancer Institute Community Oncology Research Program, Dayton, OH (T.S.); National Cancer Institute, Bethesda, MD (J.J.W.); and the Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ (A.C.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447029PMC
December 2018

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance).

Int J Stat Med Res 2018 16;7(4):137-146. Epub 2018 Nov 16.

Division of Biomedical Statistics and Bioinformatics, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6000/1929-6029.2018.07.04.4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686677PMC
November 2018

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

J Clin Oncol 2018 Sep 11:JCO2018788620. Epub 2018 Sep 11.

Ethan Basch, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Bryce B. Reeve, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Ethan Basch, Lauren J. Rogak, Mary C. Shaw, Narre Heon, and Martin R. Weiser, Memorial Sloan Kettering Cancer Center, New York, NY; Amylou C. Dueck and Brenda Ginos, Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ; Sandra A. Mitchell, Lori M. Minasian, and Andrea M. Denicoff, National Cancer Institute, Rockville, MD; Jennifer K. Wind, Harvey J. Mamon, and Deborah Schrag, Dana-Farber/Partners CancerCare, Boston, MA; Qian Shi, Garth D. Nelson, and Jeffrey P. Meyers, Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; George J. Chang, University of Texas MD Anderson Cancer Center, Houston, TX; Tatjana Kolevska, Kaiser Permanente Vallejo Medical Center, Vallejo, CA; and Deborah Watkins Bruner, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209091PMC
September 2018

Patient-Reported Symptom Monitoring During Chemotherapy-Reply.

JAMA 2017 11;318(19):1935-1936

Mayo Clinic, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2017.14903DOI Listing
November 2017

Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials.

Leuk Res 2017 08 12;59:26-31. Epub 2017 May 12.

Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.05.012DOI Listing
August 2017

Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype.

Am J Clin Nutr 2017 Aug 7;106(2):447-456. Epub 2017 Jun 7.

Department of Molecular Pharmacology and Experimental Therapeutics and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.117.156943DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525122PMC
August 2017

Determination of mild, moderate, and severe pain interference in patients with cancer.

Pain 2017 06;158(6):1108-1112

aDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA bDepartment of Biostatistics, Mayo Clinic in Arizona, Scottsdale, AZ, USA cAmgen, Thousand Oaks, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000000890DOI Listing
June 2017

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

Clin Genitourin Cancer 2017 04 8;15(2):196-202.e1. Epub 2016 Sep 8.

Department of Urology, Mayo Clinic Arizona, Phoenix, AZ. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.08.026DOI Listing
April 2017

Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.

Neuro Oncol 2017 01 8;19(1):128-137. Epub 2016 Aug 8.

Department of Radiology, Mayo Clinic, Phoenix, Arizona (L.S.H., T.W., J.M.H.); Department of Biostatistics, Mayo Clinic, Phoenix, Arizona (A.C.D.); Department of Research, Mayo Clinic, Arizona (J.R.M., K.S.); Department of Neurosurgery, Mayo Clinic, Phoenix, Arizona (K.R.S.); Department of Cancer and Cell Biology, Mayo Clinic, Scottsdale, Arizona (J.C.L.); Department of Pathology, Mayo Clinic, Rochester, Minnesota (R.B.J., T.M.K.); Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota (H.S.); Department of Neuro-oncology, Mayo Clinic, Rochester, Minnesota (B.P.O.); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (J.S.); Department of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota (W.E.); Department of Cancer and Cell Biology, Translational Genomics Research Institute, Phoenix, Arizona (S.P., N.L.T.); School of Computing, Informatics and Decision Systems Engineering, Arizona State University, Tempe, Arizona (J.L., T.W., S.N., N.G.); Department of Biomedical Informatics, Arizona State University, Tempe, Arizona (S.R.); School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona (J.P., D.F.); Department of Pathology, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (J.M.E.); Department of Neurosurgery, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (K.A.S., P.N.); Department of Radiology, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (L.C.B., J.P. K., L.S.H.); Department of Imaging Research, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (C.C.Q.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193022PMC
January 2017

Safety and interaction of patients with implantable cardiac defibrillators driving a hybrid vehicle.

Int J Cardiol 2017 Jan 9;227:318-324. Epub 2016 Nov 9.

Heart Rhythm Section, Department of Cardiology, Mayo Clinic, AZ, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.11.090DOI Listing
January 2017

A statistician's perspective on a long time to publish.

Authors:
Amylou C Dueck

Lancet Haematol 2017 Jan 2;4(1):e12. Epub 2016 Dec 2.

Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(16)30183-1DOI Listing
January 2017

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.

Am J Hematol 2016 12 11;91(12):E504-E505. Epub 2016 Oct 11.

Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24548DOI Listing
December 2016

Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

Exp Hematol 2016 Dec 31;44(12):1138-1155.e4. Epub 2016 Aug 31.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biomedical and Neuromotorial Sciences, Alma Mater University, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778911PMC
December 2016

Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center.

Am J Surg 2016 Dec 29;212(6):1201-1210. Epub 2016 Sep 29.

Section of Surgical Oncology, Department of Surgery, Mayo Clinic Arizona, 5777 E. Mayo Blvd, Phoenix, AZ 85054, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2016.08.020DOI Listing
December 2016

Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.

Ann Surg Oncol 2015 Dec 19;22 Suppl 3:S516-21. Epub 2015 May 19.

Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4607-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653087PMC
December 2015

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development.

Mediators Inflamm 2015 11;2015:284706. Epub 2015 Oct 11.

Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ 85054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/284706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619953PMC
August 2016

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

J Natl Cancer Inst 2016 08 20;108(8). Epub 2016 Apr 20.

Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017935PMC
August 2016

Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data.

Expert Opin Drug Discov 2016 Aug 16;11(8):753-8. Epub 2016 Jun 16.

b Department of Health Sciences Research , Mayo Clinic , Scottsdale , AZ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2016.1193148DOI Listing
August 2016

Impact of Personality on Cognitive Aging: A Prospective Cohort Study.

J Int Neuropsychol Soc 2016 08 27;22(7):765-76. Epub 2016 Jun 27.

5Department of Psychiatry,Mayo Clinic Arizona,Scottsdale,Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1355617716000527DOI Listing
August 2016

Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma.

Dermatol Surg 2016 May;42(5):646-52

*Department of Dermatology, Mayo Clinic, Scottsdale, Arizona; †Division of Dermatology, LewisGale Hospital Montgomery, Blacksburg, Virginia; ‡Section of Biostatistics, Mayo Clinic, Scottsdale, Arizona; §Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000000702DOI Listing
May 2016

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.

J Clin Oncol 2016 Apr 23;34(10):1034-42. Epub 2015 Nov 23.

Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium; Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium; Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ; Giuseppe Viale, University of Milan, Milan, Italy; Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy; Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland; Alison Armour, GlaxoSmithKline, Collegeville, PA; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada; Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China; Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; Holger Eidtmann, University Hospital Kiel, Kiel, Germany; Phuong Dinh, Breast International Group, Brussels, Belgium; Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy; Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain; Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany; Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia; Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea; Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea; Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China; Véronique Diéras, Institut Curie, Paris, France; David W. Hillman, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Christian Jackisch, Klinikum Offenba

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872016PMC
April 2016

Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.

Clin Ther 2016 04 2;38(4):821-30. Epub 2016 Apr 2.

Section of Biostatistics, Mayo Clinic, Scottsdale, Arizona. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2016.03.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851916PMC
April 2016

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

J Clin Oncol 2016 Feb 7;34(6):557-65. Epub 2015 Dec 7.

Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children's Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic, Rochester, MN; and Deborah Schrag, Dana-Farber/Harvard Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872028PMC
February 2016

Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.

Cancer 2016 Feb 15;122(3):477-85. Epub 2015 Dec 15.

Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29753DOI Listing
February 2016

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

J Clin Oncol 2016 Jan 23;34(2):151-9. Epub 2015 Nov 23.

Holly Geyer, Robyn Scherber, Heidi Kosiorek, Amylou C. Dueck, and Ruben A. Mesa, Mayo Clinic, Scottsdale, AZ; Jean-Jacques Kiladjian, Hospital Saint-Louis, Paris; Francoise Boyer, Centre Hospitalier Universitaire, Angers; Gabriel Etienne, Institut Bergonie, Bordeaux; Jean-Christophe Ianotto, Centre Hospitalier Universitaire, Brest; Dana Ranta, Centre Hospitalier Universitaire, Grenoble; Lydia Roy, Centre Hospitalier Universitaire, Poitiers; Jean-Yves Cahn, Centre Hospitalier Universitaire, Grenoble, France; Zhijian Xiao, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, and Peihong Zhang, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Stefanie Slot and Sonja Zweegman, VU University Medical Center, Amsterdam; Peter A.W. te Boekhorst, Erasmus Medical Center, Rotterdam; Suzan Commandeur, Leiden University Medical Center, Leiden; Harry Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Frederico Sackmann, Fundaleu, Buenos Aires, Argentina; Ana Kerguelen Fuentes and Dolores Hernández-Maraver, University Hospital La Paz, Madrid; Carlos Besses, Hospital del Mar; Francisco Cervantes, University of Barcelona, Barcelona, Spain; Konstanze Döhner and Frank Stegelmann, University Hospital of Ulm; Karin Bonatz and Andreas Reiter, Universitätsmedizin Mannheim, Mannheim; Heike L. Pahl, University Hospital Freiburg, Freiburg; Martin Griesshammer, Johannes Wesling Klinikum Minden, Germany; Claire N. Harrison and Deepti Radia, Guy's and St Thomas NHS Foundation Trust; Robert Peter Gale, Imperial College, London, United Kingdom; Pablo Muxi, Hospital Británico, Montevideo, Uruguay; Peter L. Johansson and Bjorn Andreasson, NU Hospital Organization, Uddevalla; Gunnar Birgegard, University Hospital, Uppsala; Jan Samuelsson, Stockholm South Hospital, Stockholm, Sweden; Alessandro Rambaldi, Tiziano Barbui, and Maria L. Ferrari, Ospedali Riuniti di Bergamo, Bergamo; Giovanni Barosi, IRCCS Policlinico S. Matteo Foundation; Franc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.9337DOI Listing
January 2016

Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.

Ann Surg Oncol 2015 Dec 19;22 Suppl 3:S516-21. Epub 2015 May 19.

Department of Surgery, Section of Surgical Oncology, Mayo Clinic, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4607-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653087PMC
December 2015

Regional recurrence in the era of sentinel lymph node biopsy.

Am J Surg 2015 Dec 28;210(6):1155-60; discussion 1160-1. Epub 2015 Sep 28.

Department of General Surgery, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2015.09.001DOI Listing
December 2015

Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls.

Am J Hematol 2015 Oct 10;90(10):864-70. Epub 2015 Sep 10.

Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24098DOI Listing
October 2015

Validation of a gastric cancer nomogram using a cancer registry.

J Surg Oncol 2015 Sep 14;112(4):377-80. Epub 2015 Aug 14.

Department of Surgery, Section of Surgical Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jso.23999
Publisher Site
http://dx.doi.org/10.1002/jso.23999DOI Listing
September 2015

Rates of residual disease with close but negative margins in breast cancer surgery.

Breast 2015 Aug 4;24(4):413-7. Epub 2015 Apr 4.

Department of Surgery, Division of Surgical Oncology, Mayo Clinic, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.03.005DOI Listing
August 2015

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

J Clin Oncol 2015 Mar 20;33(7):701-8. Epub 2015 Jan 20.

Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334774PMC
March 2015

Association of hospital participation in a surgical outcomes monitoring program with inpatient complications and mortality.

JAMA 2015 Feb;313(5):505-11

Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Surgical Outcomes Division, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.90DOI Listing
February 2015

Sex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct?

J Int Neuropsychol Soc 2015 Feb 9;21(2):95-104. Epub 2015 Feb 9.

1Department of Neurology,Mayo Clinic Arizona,Scottsdale,Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1355617715000016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785799PMC
February 2015

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

J Natl Cancer Inst 2014 Sep 29;106(9). Epub 2014 Sep 29.

: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC (EB, BBR, AVB); Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC (EB, BBR, AVB); Department of Epidemiology and Biostatistics, Health Outcomes Research Group (EB, LS, LR) and Department of Psychiatry and Behavioral Sciences (JH, TMA), Memorial Sloan Kettering Cancer Center, New York, NY; Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences (SAM, SBC), Division of Cancer Prevention (LMM), NCTN Clinical Trials Operations, Cancer Therapy Evaluation Program (AD), Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention (AMO, DSG, JK), and Investigational Drug Branch, Cancer Therapy Evaluation Program (AC), National Cancer institute, Bethesda, MD;Division of Health Sciences Research, College of Medicine, Mayo Clinic - Arizona, Scottsdale, AZ (ACD); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (TRM, CSC); Patient Advocate, New York, NY (DBP); Department of Medicine, Duke Center for Learning HealthCare, Duke Cancer Research Program, Duke University, Durham, NC (APA); Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute of Emory University, Emory University, Atlanta, GA (DWB); Mayo Clinic - Rochester, Rochester, MN (JAS); SemanticBits LLC, Herndon, VA (RC, PB); Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA (AB); Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (DS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200059PMC
September 2014